Literature DB >> 17161072

Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study.

Rickard Carlhed1, Mats Bojestig, Lars Wallentin, Gunilla Lindström, Anette Peterson, Christina Aberg, Bertil Lindahl.   

Abstract

BACKGROUND: The adherence to evidence-based treatment guidelines for acute myocardial infarction (AMI) is still suboptimal. Therefore, we designed a study to evaluate the effects of a collaborative quality improvement (QI) intervention on the adherence to AMI guidelines. The intervention used a national web-based quality registry to generate local and regular real-time performance feedback.
METHODS: A 12-month baseline measurement of the adherence rates was retrospectively collected, comprising the period July 1, 2001, through June 30, 2002. During the intervention period of November 1, 2002, through April 30, 2003, multidisciplinary teams from 19 nonrandomized intervention hospitals were subjected to a multifaceted QI-oriented intervention. Another 19 hospitals, unaware of their status as controls, were matched to the intervention hospitals. During the postintervention measurement period of May 1, 2003, through April 30, 2004, a total of 6726 consecutive patients were included at the intervention (n = 3786) and control (n = 2940) hospitals. The outcome measures comprised 5 Swedish national guideline-derived quality indicators, compared between baseline and postintervention levels in the control and QUICC intervention hospitals.
RESULTS: In the control and QI intervention hospitals, the mean absolute increase of patients receiving angiotensin-converting enzyme inhibitors was 1.4% vs 12.6% (P = .002), lipid-lowering therapy 2.3% vs 7.2% (P = .065), clopidogrel 26.3% vs 41.2% (P = .010), heparin/low-molecular weight heparin 5.3% vs 16.3% (P = .010), and coronary angiography 6.2% vs 16.8% (P = .027), respectively. The number of QI intervention hospitals reaching a treatment level of at least 70% in 4 or 5 of the 5 indicators was 15 and 5, respectively. In the control group, no hospital reached 70% or more in just 4 of the 5 indicators.
CONCLUSIONS: By combining a systematic and multidisciplinary QI collaborative with a web-based national quality registry with functionality allowing real-time performance feedback, major improvements in the adherence to national AMI guidelines can be achieved.

Entities:  

Mesh:

Year:  2006        PMID: 17161072     DOI: 10.1016/j.ahj.2006.07.028

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.

Authors:  Rikke Sørensen; G H Gislason; E L Fosbøl; S Rasmussen; L Køber; J K Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

Review 2.  Understanding the components of quality improvement collaboratives: a systematic literature review.

Authors:  Erum Nadeem; S Serene Olin; Laura Campbell Hill; Kimberly Eaton Hoagwood; Sarah McCue Horwitz
Journal:  Milbank Q       Date:  2013-06       Impact factor: 4.911

3.  Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.

Authors:  Martin Höglund; Fredrik Sandin; Karin Hellström; Mats Björeman; Magnus Björkholm; Mats Brune; Arta Dreimane; Marja Ekblom; Sören Lehmann; Per Ljungman; Claes Malm; Berit Markevärn; Kristina Myhr-Eriksson; Lotta Ohm; Ulla Olsson-Strömberg; Anders Själander; Hans Wadenvik; Bengt Simonsson; Leif Stenke; Johan Richter
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

4.  Hospital-Based Quality Improvement Interventions for Patients With Acute Coronary Syndrome: A Systematic Review.

Authors:  Ehete Bahiru; Anubha Agarwal; Mark A Berendsen; Abigail S Baldridge; Tecla Temu; Amy Rogers; Carey Farquhar; Frederick Bukachi; Mark D Huffman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-09-06

Review 5.  What is the value and impact of quality and safety teams? A scoping review.

Authors:  Deborah E White; Sharon E Straus; H Tom Stelfox; Jayna M Holroyd-Leduc; Chaim M Bell; Karen Jackson; Jill M Norris; W Ward Flemons; Michael E Moffatt; Alan J Forster
Journal:  Implement Sci       Date:  2011-08-23       Impact factor: 7.327

6.  Recentralizing healthcare through evidence-based guidelines - striving for national equity in Sweden.

Authors:  Mio Fredriksson; Paula Blomqvist; Ulrika Winblad
Journal:  BMC Health Serv Res       Date:  2014-11-05       Impact factor: 2.655

7.  Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design.

Authors:  Marcus D Flather; Jean Booth; Daphne Babalis; Hector Bueno; Philippe G Steg; Grzegorz Opolski; Filippo Ottani; Jacques Machecourt; Alfredo Bardaji; Mats Bojestig; Anthony R Brady; Bertil Lindahl
Journal:  Trials       Date:  2010-01-14       Impact factor: 2.279

8.  Health Care Quality Improvement for ST-Segment Elevation Myocardial Infarction: A Retrospective Study Based on Propensity-Score Matching Analysis.

Authors:  Junxiong Ma; Xuejie Dong; Yinzi Jin; Zhi-Jie Zheng
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

9.  Quality improvement in coronary care: analysis of sustainability and impact on adjacent clinical measures after a Swedish controlled, multicenter quality improvement collaborative.

Authors:  Rickard Carlhed; Christina Bellman; Mats Bojestig; Leif Bojö; Anette Peterson; Bertil Lindahl
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

10.  Use of a national collaborative to improve hospital quality in a low-income setting.

Authors:  Erika Linnander; Zahirah McNatt; Heather Sipsma; Dawit Tatek; Yigeremu Abebe; Abraham Endeshaw; Elizabeth H Bradley
Journal:  Int Health       Date:  2016-01-20       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.